Prevalence of disordered eating behaviors in diabetics probed

Tweet

AUGUSTA, Ga. - Children with diabetes are at an increased risk for developing eating disorders and researchers want to know if it's their disease or treatment that's to blame.

Promising results from 2 trials highlighting pomalidomide presented at ASH

Tweet

BOUDRY, Switzerland--(December 10, 2008)--Celgene International Sarl (Nasdaq: CELG) today announced that its next IMiDs compound, pomalidomide, has shown promising activity with manageable safety and tolerability for the treatment of relapsed/refractory multiple myeloma (MM) and myelofibrosis. The data were presented at the 50th Annual American Society of Hematology meeting in San Francisco, CA.

Analysis shows revlimid plus dexamethasone increases overall survival in multiple myeloma patients

Tweet

Analysis shows that vidaza prolongs survival in patients with higher-risk myelodysplastic syndromes

Tweet

Crosswicks, NJ – (December 10, 2008) – The Myelodysplastic Syndromes (MDS) Foundation announced today that a subanalysis of the AZA-001 phase III international clinical trial shows that treatment with VIDAZA (azacitidine) can extend overall survival and reduce the risk of death in elderly higher-risk MDS patients.

Data presented at ASH illustrates that continued treatment with vidaza can benefit MDS patients

Tweet

Crosswicks, NJ – (December 10, 2008) – The Myelodysplastic Syndromes (MDS) Foundation announced today that a new analysis of the AZA-001 phase III clinical trial demonstrates that continued treatment with VIDAZA (azacitidine) can improve response rates for higher-risk MDS patients.

Data presented demonstrate prolonged overall survival for patients with acute myeloid leukemia

Tweet

Crosswicks, NJ – (December10, 2008) – The Myelodysplastic Syndromes (MDS) Foundation announced today that data presented at this year's American Society of Hematology (ASH) Meeting in San Francisco demonstrate that patients with acute myeloid leukemia (AML) who were treated with VIDAZA (azacitidine) had significantly increased overall survival compared to those treated with conventional care regimens (CCR).

Hebrew SeniorLife study on under-reported dementia deaths questions accuracy of mortality statistics

Tweet

(Boston, Mass.) – Deaths due to dementia and Alzheimer's disease are underreported on death certificates, according to a study conducted by Hebrew SeniorLife's Institute for Aging Research (IFAR), raising concerns about the accuracy of mortality statistics based on these documents.

If MRI shows signs of MS, will the disease develop?

Tweet

ST. PAUL, Minn. – With more and more people having brain MRIs for various reasons, doctors are finding people whose scans show signs of multiple sclerosis (MS) even though they have no symptoms of the disease. A new study published in the December 10, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology, found that a third of these people developed MS within an average of about five years.

13 new technologies in computer graphics and interactive techniques showcased by Singapore's A*STAR

Tweet

A total of 13 new technologies in computer graphics and interactive techniques, including 3D graphics and animation, intuitive human-computer interaction technologies and neural signal processing, will be introduced by Singapore's A*STAR (Agency for Science, Technology and Research) at Asia's version of the world's largest and most prestigious computer graphics show, SIGGRAPH (Special Interest Group on GRAPHics and Interactive Techniques).

Cellular 'brakes' may slow memory process in aging brains

Tweet

GAINESVILLE, Fla. — University of Florida researchers may have discovered why some brain cells necessary for healthy memory can survive old age or disease, while similar cells hardly a hairsbreadth away die.

The discovery, published online ahead of print in the Nature publication Cell Death & Differentiation, could help scientists understand and find solutions for age-related memory loss.